HEADER VIRAL PROTEIN 27-MAR-18 6CV8 TITLE HADDOCK STRUCTURE OF THE ROUS SARCOMA VIRUS MATRIX PROTEIN (M-DOMAIN) TITLE 2 IN COMPLEX WITH INOSITOL 1,4,5-TRISPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN P19; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ROUS SARCOMA VIRUS; SOURCE 3 ORGANISM_COMMON: RSV-PRC; SOURCE 4 ORGANISM_TAXID: 11888; SOURCE 5 STRAIN: PRAGUE C; SOURCE 6 GENE: GAG-POL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RSV, ASV, GAG, IP3, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.VLACH,J.S.SAAD REVDAT 6 15-MAY-24 6CV8 1 REMARK REVDAT 5 14-JUN-23 6CV8 1 REMARK REVDAT 4 06-NOV-19 6CV8 1 REMARK REVDAT 3 19-DEC-18 6CV8 1 JRNL REVDAT 2 28-NOV-18 6CV8 1 JRNL REVDAT 1 24-OCT-18 6CV8 0 JRNL AUTH J.VLACH,G.N.EASTEP,R.H.GHANAM,S.M.WATANABE,C.A.CARTER, JRNL AUTH 2 J.S.SAAD JRNL TITL STRUCTURAL BASIS FOR TARGETING AVIAN SARCOMA VIRUS GAG JRNL TITL 2 POLYPROTEIN TO THE PLASMA MEMBRANE FOR VIRUS ASSEMBLY. JRNL REF J. BIOL. CHEM. V. 293 18828 2018 JRNL REFN ESSN 1083-351X JRNL PMID 30309983 JRNL DOI 10.1074/JBC.RA118.003944 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CV8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000233428. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 305 REMARK 210 PH : 6 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 100 UM [U-98% 15N] MATRIX REMARK 210 PROTEIN, 50 MM SODIUM PHOSPHATE, 2 MM TCEP, 1.6 MM D-MYO- REMARK 210 INOSITOL-1,4,5-TRIPHOSPHATE, 95% H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, ANALYSIS, HADDOCK REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 2 -36.21 -174.16 REMARK 500 1 CYS A 16 -49.23 -138.19 REMARK 500 1 ILE A 64 -74.73 -86.16 REMARK 500 2 GLU A 2 -36.27 -174.11 REMARK 500 2 CYS A 16 -49.33 -138.17 REMARK 500 2 ILE A 64 -74.81 -86.06 REMARK 500 3 GLU A 2 -36.16 -174.20 REMARK 500 3 CYS A 16 -49.27 -138.23 REMARK 500 3 ILE A 64 -74.79 -86.16 REMARK 500 4 GLU A 2 -36.21 -174.14 REMARK 500 4 CYS A 16 -49.36 -138.12 REMARK 500 4 ILE A 64 -74.66 -86.15 REMARK 500 5 GLU A 2 -36.29 -174.06 REMARK 500 5 CYS A 16 -49.33 -138.19 REMARK 500 5 ILE A 64 -74.78 -86.15 REMARK 500 6 GLU A 2 -36.32 -174.07 REMARK 500 6 CYS A 16 -49.25 -138.13 REMARK 500 6 ILE A 64 -74.80 -86.19 REMARK 500 7 GLU A 2 -36.27 -174.06 REMARK 500 7 CYS A 16 -49.23 -138.16 REMARK 500 7 ILE A 64 -74.79 -86.16 REMARK 500 8 GLU A 2 -36.26 -174.14 REMARK 500 8 CYS A 16 -49.28 -138.12 REMARK 500 8 ILE A 64 -74.71 -86.23 REMARK 500 9 GLU A 2 -36.31 -174.06 REMARK 500 9 CYS A 16 -49.23 -138.23 REMARK 500 9 ILE A 64 -74.81 -86.06 REMARK 500 10 GLU A 2 -36.34 -174.12 REMARK 500 10 CYS A 16 -49.28 -138.17 REMARK 500 10 ILE A 64 -74.74 -86.23 REMARK 500 11 GLU A 2 -36.18 -174.10 REMARK 500 11 CYS A 16 -49.30 -138.17 REMARK 500 11 ILE A 64 -74.79 -86.14 REMARK 500 12 GLU A 2 -36.23 -174.02 REMARK 500 12 CYS A 16 -49.19 -138.22 REMARK 500 12 ILE A 64 -74.79 -86.09 REMARK 500 13 GLU A 2 -36.27 -174.10 REMARK 500 13 CYS A 16 -49.21 -138.20 REMARK 500 13 ILE A 64 -74.77 -86.18 REMARK 500 14 GLU A 2 -36.09 -174.10 REMARK 500 14 CYS A 16 -49.30 -138.17 REMARK 500 14 ILE A 64 -74.76 -86.11 REMARK 500 15 GLU A 2 -36.15 -174.09 REMARK 500 15 CYS A 16 -49.41 -138.15 REMARK 500 15 ILE A 64 -74.80 -86.12 REMARK 500 16 GLU A 2 -36.29 -174.09 REMARK 500 16 CYS A 16 -49.31 -138.19 REMARK 500 16 ILE A 64 -74.76 -86.09 REMARK 500 17 GLU A 2 -36.25 -174.08 REMARK 500 17 CYS A 16 -49.35 -138.16 REMARK 500 REMARK 500 THIS ENTRY HAS 60 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue I3P A 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6CE5 RELATED DB: PDB REMARK 900 MA STRUCTURE USED FOR DOCKING REMARK 900 RELATED ID: 30404 RELATED DB: BMRB REMARK 900 RELATED ID: 6CUS RELATED DB: PDB DBREF 6CV8 A 1 87 UNP P03354 POL_RSVP 1 87 SEQADV 6CV8 SER A 1 UNP P03354 MET 1 ENGINEERED MUTATION SEQRES 1 A 87 SER GLU ALA VAL ILE LYS VAL ILE SER SER ALA CYS LYS SEQRES 2 A 87 THR TYR CYS GLY LYS THR SER PRO SER LYS LYS GLU ILE SEQRES 3 A 87 GLY ALA MET LEU SER LEU LEU GLN LYS GLU GLY LEU LEU SEQRES 4 A 87 MET SER PRO SER ASP LEU TYR SER PRO GLY SER TRP ASP SEQRES 5 A 87 PRO ILE THR ALA ALA LEU SER GLN ARG ALA MET ILE LEU SEQRES 6 A 87 GLY LYS SER GLY GLU LEU LYS THR TRP GLY LEU VAL LEU SEQRES 7 A 87 GLY ALA LEU LYS ALA ALA ARG GLU GLU HET I3P A 101 34 HETNAM I3P D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE FORMUL 2 I3P C6 H15 O15 P3 HELIX 1 AA1 ALA A 3 SER A 10 1 8 HELIX 2 AA2 ALA A 11 CYS A 16 1 6 HELIX 3 AA3 GLY A 17 SER A 20 5 4 HELIX 4 AA4 SER A 22 GLU A 36 1 15 HELIX 5 AA5 SER A 41 SER A 47 5 7 HELIX 6 AA6 SER A 50 GLY A 66 1 17 HELIX 7 AA7 GLU A 70 ARG A 85 1 16 SITE 1 AC1 6 LYS A 6 SER A 9 LYS A 13 SER A 22 SITE 2 AC1 6 LYS A 23 LYS A 24 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1